Sarpogrelate hydrochloride reduced intimal hyperplasia in experimental rabbit vein graft

Journal of Vascular Surgery

Volumn 49, Issue 5, 2009, Pages 1272-1281

  Kodama, Akio ^a   Komori, Kimihiro ^a   Hattori, Keisuke ^a   Yamanouchi, Dai ^a   Kajikuri, Junko ^b   Itoh, Takeo ^b  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; PROSTAGLANDIN F2 ALPHA; SARPOGRELATE; SUPEROXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY INTIMA PROLIFERATION; ARTICLE; BYPASS SURGERY; CONTROLLED STUDY; ENDOTHELIUM CELL; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RABBIT; VEIN DILATATION; VEIN GRAFT;

ACETYLCHOLINE; ADMINISTRATION, ORAL; ANIMALS; CAROTID ARTERIES; CELL PROLIFERATION; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; HYPERPLASIA; JUGULAR VEINS; MALE; MODELS, ANIMAL; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; NITROARGININE; RABBITS; RECEPTOR, SEROTONIN, 5-HT2A; SEROTONIN ANTAGONISTS; SUCCINATES; SUPEROXIDES; TUNICA INTIMA; VASODILATION; VASODILATOR AGENTS;

EID: 64949182058     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvs.2008.11.071     Document Type: Article

References (31)

1. Mori E., Komori K., Kume M., Yamaoka T., Shoji T., Furuyama T., and Inoguchi H. Comparison of the long-term results between surgical and conservative treatment in patients with intermittent claudication. Surgery 131 1 Suppl (2002) 269-274
2. Davies M.G., and Hagen P.O. Pathophysiology of vein graft failure: a review. Eur J Vasc Endovasc Surg 9 (1995) 7-18
3. Motwani J.G., and Topol E.J. Aortocoronary saphenous vein graft disease: pathogenesis, predisposition, and prevention. Circulation 97 (1998) 916-931
4. Morinaga K., Eguchi H., Miyazaki T., Okadome K., and Sugimachi K. Development and regression of intimal thickening of arterially transplanted autologous vein grafts in dogs. J Vasc Surg 5 (1987) 719-730
5. Komori K., Yamamura S., Ishida M., Matsumoto T., Kuma S., Eguchi D., et al. Acceleration of impairment of endothelium-dependent response under poor runoff conditions in canine autogenous vein grafts. Eur J Vasc Endovasc Surg 14 (1997) 475-481
6. Komori K., Gloviczki P., Bourchier R.G., Miller V.M., and Vanhoutte P.M. Endothelium-dependent vasorelaxations in response to aggregating platelets are impaired in reversed vein grafts. J Vasc Surg 12 (1990) 139-147
7. Okazaki J., Komori K., Kawasaki K., Eguchi D., Ishida M., and Sugimachi K. L-arginine inhibits smooth muscle cell proliferation of vein graft intimal thickness in hypercholesterolemic rabbits. Cardiovasc Res 36 (1997) 429-436
8. Saini H.K., Takeda N., Goyal R.K., Kumamoto H., Ameja A.S., and Dhalla N.S. Therapeutic potentials of sarpogrelate in cardiovascular disease. Cardiovasc Drug Rev 22 (2004) 27-54
9. Nakamura K., Kariyazono H., Masuda H., Sakata R., and Yamada K. Effects of sarpogrelate hydrochloride on adenosine diphosphate- or collagen-induced platelet responses in arteriosclerosis obliterans. Blood Coagul Fibrinolysis 12 (2001) 391-397
10. Miyazaki M., Higashi Y., Goto C., Chayama K., Yoshizumi M., Sanada H., et al. Sarpogrelate hydrochloride, a selective 5-HT2A antagonist, improves vascular function in patients with peripheral arterial disease. J Cardiovasc Pharmacol 49 (2007) 221-227
11. 2 receptor antagonist, reduces stenosis induced by balloon injury in the hypercholesterolaemic rabbit. Int Angiol 16 (1997) 204-209
12. 2A antagonist, retards the progression of atherosclerosis through a novel mechanism. Atherosclerosis 168 (2003) 23-31
13. Banno H., Takei Y., Muramatsu T., Komori K., and Kadomatsu K. Controlled release of small interfering RNA targeting midkine attenuates intimal hyperplasia in vein grafts. J Vasc Surg 44 (2006) 633-641
14. Yamanouchi D., Banno H., Nakayama M., Sugimoto M., Fujita H., Kobayashi M., et al. Hydrophillic statin suppresses vein graft intimal hyperplasia via endothelial cell-tropic Rho-kinase inhibition. J Vasc Surg 42 (2005) 757-764
15. Jiang Z., Wu L., Miller B.L., Goldman D.R., Fernandez C.M., Abouhamze Z.S., et al. A novel vein graft model: adaptation to differential flow environments. Am J Physiol Heart Circ Physiol 286 (2004) H240-H245
16. Takahashi K., Ino T., Ohkubo M., Akimoto K., and Kishirou M. Restenosis after balloon angioplasty of coarctation: relationship with ductus arteriosus. Pediatr Int 42 (2000) 658-667
17. Itoh T., Kajikuri J., Tada T., Suzuki Y., and Mabuchi Y. Angiotensin II-induced modulation of endothelium-dependent relaxation in rabbit mesenteric resistance arteries. J Physiol 548 Pt 3 (2003) 893-906
18. Kusama N., Kajikuri J., Watanabe Y., Suzuki Y., Katsuya H., and Itoh T. Characteristics of attenuated endothelium-dependent relaxation seen in rabbit intrapulmonary vein following chronic nitroglycerine administration. Br J Pharmacol 145 (2005) 193-202
19. Crabtree M.J., Smith C.L., Lam G., Goligorsky M.S., and Gross S.S. Ratio of 5,6,7,8-tetrahydrobiopterin to 7,8-dihydrobiopterin in endothelial cells determines glucose-elicited changes in NO vs superoxide production by eNOS. Am J Physiol Heart Circ Physiol 294 (2008) H1530-H1540
20. 2A serotonergic receptor antagonist, inhibits serotonin-induced coronary artery spasm in a porcine model. J Cardiovasc Pharmacol 35 (2000) 294-301
21. Ishida M., Komori K., Yonemitsu Y., Taguchi K., Onohara T., and Sugimachi K. Immunohistochemical phenotypic alterations of rabbit autologous vein grafts implanted under arterial circulation with or without poor distal runoff-implications of vein graft remodeling. Atherosclerosis 154 (2001) 345-354
22. Itoh H., Komori K., Funahashi S., Okadome K., and Sugimachi K. Intimal hyperplasia of experimental autologous vein graft in hyperlipidemic rabbits with poor distal runoff. Atherosclerosis 110 (1994) 259-270
23. Kim H.S., Aikawa M., Kimura K., Kuro-o M., Nakahara K., Suzuki T., et al. Ductus arteriosus. Advanced differentiation of smooth muscle cells demonstrated by myosin heavy chain isoform expression in rabbits. Circulation 88 4 Pt 1 (1993) 1804-1810
24. Zhang W.D., Bai H.Z., Sawa Y., Yamakawa T., Kadoba K., Taniguchi K., et al. Association of smooth muscle cell phenotypic modulation with extracellular matrix alterations during neointima formation in rabbit vein grafts. J Vasc Surg 30 (1999) 169-183
25. Komori K., Inoguchi H., Kume M., Shoji T., and Furuyama T. Differences in endothelial function and morphologic modulation between canine autogenous venous and arterial grafts: endothelium and intimal thicking. Surgery 131 1 Suppl (2002) S249-S255
26. Ohta S., Komori K., Yonemitsu Y., Onohara T., Matsumoto T., and Sugimachi K. Intraluminal gene transfer of endothelial cell-nitric oxide synthase suppresses intimal hyperplasia of vein grafts in cholesterol-fed rabbit: a limited biological effect as a result of the loss of medial smooth muscle cells. Surgery 131 (2002) 644-653
27. Garg U.C., and Hassid A. Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest 83 (1989) 1774-1777
28. Mikawa K., Akamatsu H., Nishina K., Shiga M., Maekawa N., Obara H., and Niwa Y. The effects of sarpogrelate on superoxide production by human neutrophils. Reg Anesth Pain Med 25 (2000) 181-186
29. Kawashima S., and Yokoyama M. Dysfunctional of endothelial nitric oxide synthase and atherosclerosis. Arterioscler Thromb Vasc Biol 24 (2004) 998-1005
30. Mata-Greenwood E., Jenkins C., Farrow K.N., Konduri G.G., Russell J.A., Lakshminrusimha S., et al. eNOS function is developmentally regulated: uncoupling of eNOS occurs postnatally. Am J Physiol Lung Cell Mol Physiol 290 (2006) L232-L241
31. Hattori K., Yamanouchi D., Banno H., Kobayashi M., Yamamoto K., Kajikuri J., et al. Celiprolol reduces the intimal thickening of autogenous vein grafts via an enhancement of nitric oxide function through an inhibition of superoxide production. J Vasc Surg 46 (2007) 116-123